epSOS

EU LSP

[John Moehrke @johnmoehrke]

Pseudonymization, the terms 'anonymization' and 'pseudonymization' described distinct technical methods for de-identifying data. Driven by regulations like GDPR and court decisions, the focus has shifted from pseudonymization as the method to pseudonymized is the dataset itself.

[epSOS @epSOSproject]

Thinking of closing down due to security issues and other trust issues. What do you suggest?

[epSOS @epSOSproject]

@escardio As former AVNRT patient who lived with it for 40+ years until it was acute enough to be caught, I support https://t.co/gKL9Jjpqi9 Keep #Researching #MedicalCommunity

[European Society of Cardiology @escardio]

#WednesdayRead

🌟 Clarifying the New Evidence Grading System! 🌟

The ESC has updated its evidence grading system for Clinical Practice Guidelines

What’s new?

· For therapy and prevention, the updated system introduces more detailed definitions of the strength of evidence. It’s actually a refinement of the robust system already in place, increasing consistency and scientific rigour.

· For the first time, there are now specific definitions of levels of evidence for diagnostic tests and prediction models. (thumbs up emoji)

Why are the updates important?

· More stringent guidance that will allow you to understand more precisely how strong the evidence is.

· Increased flexibility to enable practical clinical decision-making in scenarios where traditional evidence hierarchies may not apply

The goal? Bring you clearer insights for your decision-making process. 💡

When? The 2026 guidelines will be the first to use the updated grading system.

Read the papers in #EHJ for all the details:

Therapy and prevention here👉https://t.co/h14dfWgod6

Diagnostic tests and predication models👉https://t.co/9uiDWLuzhI

#ESCGuidelines

[epSOS @epSOSproject]

@escardio epSOS still has pulsen!

[European Society of Cardiology @escardio]

Using #ArtificialIntelligence to calculate the heart’s biological age through #ECG data predicts increased risk of mortality and #cardiovascular events 👇

#AI #HeartHealth #EHRA2025 #EHRA_ESC

[European Food Information Council (EUFIC) @EUFIC]

🔄 The way #FoodSystems are designed influences what we eat and our health.

A better #FoodEnvironment makes it easier to choose healthy, affordable and sustainable foods benefiting both people and the planet. 💪

[epSOS @epSOSproject]

#My12Anniversary   The baton has been passed, while goals have expanded the direction remains. Have the patient information follow the patient, if the patient so wishes. Brake the silos, support data sharing and reuse #EHDS

[European Society of Cardiology @escardio]

Impact of preventive substrate #catheter #ablation on implantable #cardioverter-defibrillator interventions in pts w/ #ischaemic #cardiomyopathy & #infarct-related #coronary chronic total occlusion-PREVENTIVE VT trial-visual summary #EHRA2024 #EHRA_ESC
@SergeBoveda @EmmaSvennberg

[Islet Biology Lab - UMH @isletbiologylab]

Vecchio et al. investigated how coxsackievirus B (CVB) affects human β cells and anti-CVB B T cell responses. Their data highlight limited CD8+ T cell responses to CVB, supporting the rationale for CVB vaccination trials for #type1diabetes prevention.

https://t.co/2AuOgMww7U

[World Health Organization (WHO) @WHO]

WHO statement on reported clusters of respiratory illness in children in northern China

WHO has made an official request to #China for detailed information on an increase in respiratory illnesses and reported clusters of pneumonia in children.

At a press conference on 13 November 2023, Chinese authorities from the National Health Commission reported an increase in incidence of respiratory diseases in China.
Chinese authorities attributed this increase to the lifting of COVID-19 restrictions and the circulation of known pathogens such as influenza, mycoplasma pneumoniae (a common bacterial infection which typically affects younger children), respiratory syncytial virus (RSV), and SARS-CoV-2 (the virus that causes COVID-19). Authorities stressed the need for enhanced disease surveillance in healthcare facilities and community settings, as well as strengthening the capacity of the health system to manage patients.

On 21 November, media and ProMED reported clusters of undiagnosed pneumonia in children in northern China. It is unclear if these are associated with the overall increase in respiratory infections previously reported by Chinese authorities, or separate events.

On 22 November, WHO requested additional epidemiologic and clinical information, as well as laboratory results from these reported clusters among children, through the International Health Regulations mechanism.

We have also requested further information about recent trends in the circulation of known pathogens including influenza, SARS-CoV-2, RSV and mycoplasma pneumoniae, and the current burden on health care systems.

WHO is also in contact with clinicians and scientists through our existing technical partnerships and networks in China.

Since mid-October, northern China has reported an increase in influenza-like illness compared to the same period in the previous three years. China has systems in place to capture information on trends in influenza, influenza-like illnesses, RSV, and SARS-CoV-2, and reports to platforms such as the Global Influenza Surveillance and Response System.

While WHO seeks this additional information, we recommend that people in China follow measures to reduce the risk of respiratory illness, which include recommended vaccination; keeping distance from people who are ill; staying home when ill; getting tested and medical care as needed; wearing masks as appropriate; ensuring good ventilation; and regular hand-washing.

WHO will continue to provide updates.

[Iliana Ivanova @Ili_Ivanova]

Thrilled to welcome Canada to the @HorizonEU family! 🎉

We will be able to intensify our cooperation and enable our brightest minds to tackle global challenges together.

Let's spark innovation across continents! 🇪🇺🇨🇦

👉https://t.co/kmVINxecHh

#EUCanadaSummit #HorizonEU

[European AMR Patient Group 🇪🇺 @PatientAmr]

🌍💊World AMR Awareness Week: Stories of Resilience.

🗣️Special thanks to @EpocEspana for joining us on this mission to combat #AMR by sharing valuable #PatientPerspectives.

#WAAW2023 #AMR #KeepAntibioticsWorking

[HEDIMED @HEDIMED2020]

Congratulations @HHyoty and Dr. Virginia Stone @MFT_Diabetes for receiving the Johnny Ludvigsson price 2023 🥂👏🏻

Enterovirus i fokus när Barndiabetesfondens Johnny Ludvigsson-priser delas ut https://t.co/0aFgWfuZlH

[Sylvia Thun @ProfThun]

Mütter und Väter der IPS: @epSOSproject (@sabutsch, Anna Estrelrich, Giorgio, @kainamti …..)

[Annika Strandhäll @strandhall]

Läsvärd tråd om den historieförfalskning som SD idag arbetar hårt för att sprida om socialdemokraterna och fakta om hur det egentligen låg till. Det är Sveriges historia det handlar om.
Dela gärna.

[PharmaLedger Association @PharmaLedger]

Continuing our introduction of the members who make up our association, today we recognize Bayer, representing the Standard member class. #MembershipMonday

@BayerPharma #pharmaledger #pharmaledgerassociation

[European Society of Cardiology @escardio]

#ESCardioEd challenge

❤️‍🩹 35 yo 🧑‍🦳mild hypertension
❤️‍🩹 #COVID19 infection - at home loss of consciousness after 3 days
❤️‍🩹 GCS 7, #IOT after admission, started propofol i.v.
❤️‍🩹 ECG: Ant. ST ⬆️, QTc 660 ms
❤️‍🩹 Cardiac markers ⬇️

What's your dx?

[@IHE_Catalyst @IHE_Catalyst]

Learn more about the Shared Pan-Canadian Interoperability Roadmap by tuning in Infoway podcast episode https://t.co/5Vbjsh0QqD Join Alexander Berler, Anne-Gaëlle Bergé and Daniel Berezeanu to know more about #Projectathon & #Connectathon

[epSOS @epSOSproject]

Minns du när du gick med på Twitter? Det gör jag! #MinArsdagPaTwitter